Wikipedia's Clinical Research Glossary

A Wikipedia's English Clinical Research Glossary is a English clinical research glossary that is a Wikipedia-based glossary.

• Example(s):
  • English Wikipedia's Glossary of Clinical Research [1]
  • ...
• Counter-Example(s):
  • a French Clinical Research Glossary, such as: https://notre-recherche-clinique.fr/lexique/
• See: Clinical Research Terminology.

---

---

References

2021

• (Wikipedia, 2021) ⇒ https://en.wikipedia.org/wiki/Glossary_of_clinical_research Retrieved:2021-11-6.
  • A glossary of terms used in clinical research.

• Activities of daily living
• Adverse drug reaction
• Adverse effect
• Side effect
• Adverse event
• Adverse reaction
• Animal model
• Animal study
• Approved drugs
• Arm
• Audit report
• Audit trail
• Audit
• Baseline
• Bayesian approaches
• Best practice
• Bias
• Bioavailable
• Bioinformatics
• Biological drug
• Biometrics
• Biometry
• Biostatistics
• Blinded study
• Case report form
• Case report
• Case series
• Case-control study
• Endpoint
• Outcome
• Clinical investigator
• Investigator
• Clinical practice guidelines
• Clinical researcher
• Clinical series
• Clinical study or Clinical trial
• Clinical trial protocol
• Cohort (statistics)
• Cohort study
• Community-based clinical trial (CBCT)
• Comparator
• Compassionate use trial
• Compassionate use
• Complementary and alternative therapy
• Compliance
• Confidentiality regarding trial participants
• Consecutive case series
• Content validity
• Contract Research Organization
• Contract
• Contraindication
• Control group
• Controlled trials
• Controlled clinical trial
• Data and Safety Monitoring Board or Independent Data Monitoring Committee
• Diagnostic trials
• Documentation
• Dose-dependent
• Dose
• Dose-ranging study
• Double-blind study
• Blind
• Dropout
• Drug–drug interaction
• Drug
• Efficacy
• Empirical
• Epidemiology
• Expanded access trial
• Expanded access
• Experimental drug
• Experimental
• Food and Drug Administration (FDA)
• Frequentist methods
• Good clinical practice
• Clinician
• Historic cohort study
• Human subject
• Hypothesis
• In vitro
• In vivo
• Incidence
• Indication
• Informed consent
• Inspection
• Institution
• Institutional Review Board (IRB)
• Inter-rater reliability
• Interaction (Qualitative & Quantitative)
• Advocacy and support groups
• Interim analysis
• ICH E6: Template:Citation
• ICH E9: Template:Citation
• Intra-rater reliability
• Investigational drug
• Investigational New Drug
• Investigator's Brochure
• Levels of evidence
• Masked
• Medication
• Medicine
• Meta-analysis
• Monitoring
• NCI: Template:Citation
• National Institutes of Health
• Natural history study
• New Drug Application (NDA)
• Nonconsecutive case series
• Observation
• Observational study
• Off-label
• Open label study
• Orphan drugs
• Outpatient
• Over-the-counter drug
• Patient advocate
• Peer review
• Pharmacokinetics
• Phase I clinical trials
• Phase II clinical trials
• Phase III clinical trials
• Phase IV clinical trial
• Clinical
• Pilot study
• Placebo effect
• Placebo controlled study
• Placebo
• Population study
• Preclinical
• Prevention
• Prospective cohort study
• Quality Assurance
• Quality of life trials (or supportive care trials)
• Randomization
• Randomized clinical trial
• Recruiting
• Regimen
• Retrospective cohort study
• Retrospective
• Risk-benefit ratio
• Control
• Selection bias
• Single blind study
• Sponsor
• Standard Operating Procedures
• Standard treatment
• Standards of care
• Statistical significance
• Significant
• Study endpoint
• t-test
• 21CFR312.3: Template:Citation
• 21CFR50.3: Template:Citation
• Toxicity
• Treatment IND
• NLM: Template:Citation
• Applicable regulatory requirement
• Approval (in relation to institutional review boards (IRBs))
• Audit certificate
• Blind review
• Clinical investigation
• Clinical Trial/Study Report
• Control animal
• Coordinating Committee
• Coordinating Investigator
• Direct Access
• Dose-limiting
• Dose-rate
• Double-dummy
• Eligibility criteria
• Enrolling
• Equivalence trial
• Essential Documents
• Evaluable disease
• Evaluable patients
• Follow-up
• Full analysis set
• Generalisability, Generalisation
• Global assessment variable
• Healthy control
• Historical control subject
• Impartial Witness
• Inclusion/exclusion criteria
• Independent Ethics Committee
• Informed consent document
• Intent to treat
• Interim Clinical Trial/Study Report
• Intervention group
• Intervention name
• Intervention
• Investigational
• Legally Acceptable Representative
• Maximum tolerated dose
• Monitoring Report
• Multicenter study
• Multidisciplinary opinion
• Multiplicity
• Non-inferiority trial
• Nonblinded
• Nonclinical Study
• Nonrandomized clinical trial
• Objective improvement
• Objective response
• Per protocol set (Valid Cases, Efficacy Sample, Evaluable Subjects Sample)
• Phase I/II trial
• Phase II/III trial
• Placebo therapy
• Predictive factor
• Prevention trials
• Preventive
• Primary endpoint
• Prospective
• Protocol Amendment
• Quality Control
• Recruitment status
• Regulatory Authorities
• Retrospective study
• Safety & tolerability
• Screening trials
• Serious Adverse Event
• Sham therapy
• Source Data
• Source Documents
• Sponsor-Investigator
• Statistical analysis plan
• Study type
• Subinvestigator
• Subject Identification Code
• Subject/Trial Subject
• Superiority trial
• Surrogate variable
• Test article
• Treatment effect
• Treatment emergent
• Treatment trials
• Trial Site
• Trial statistician
• Uncontrolled study
• Unexpected Adverse Drug Reaction
• Vulnerable Subjects
• Well-being of the trial subjects

---